Vancomycin-induced thrombocytopenia in endocarditis: A case report and review of literature
- PMID: 33728314
- PMCID: PMC7942037
- DOI: 10.12998/wjcc.v9.i7.1696
Vancomycin-induced thrombocytopenia in endocarditis: A case report and review of literature
Abstract
Background: Thrombocytopenia is a serious complication in the medical practice of numerous drugs. Vancomycin is frequently used for the prophylaxis and treatment of suspected or identified methicillin-resistant positive infections. Several cases with vancomycin-induced thrombocytopenia (VIT) have been reported. However, these have rarely been extensively reviewed. The present report describes a case of VIT in endocarditis, and reviews all VIT cases reported in the literature.
Case summary: A 26-year-old male diagnosed with infective endocarditis was admitted. The patient was treated with multiple drugs, including vancomycin, which was initially intravenously given at 1000 mg every 12 h and subsequently at 500 mg every 8 h on day 3. On day 11, the platelet count decreased to 51 × 109/L, vancomycin was switched to 500 mg every 12 h, and platelet transfusion was given. On day 17, the platelet count dropped to 27 × 109/L, and platelet transfusion was administered again. On day 23, vancomycin was adjusted to 500 mg every 8 h as the trough concentration dropped to the minimum effective concentration. On day 33, the platelet count declined to approximately 40 × 109/L. After platelet transfusion, the platelet count rebounded to 90 × 109/L on day 35 but dropped again to 42 × 109/L on day 43. Based on the time-to-platelet count curve and Naranjo's Adverse Drug Reaction Probability Scale score, VIT was suspected. After vancomycin discontinuation and platelet transfusion, the platelet count gradually normalized.
Conclusion: The diagnosis of VIT can be achieved through the time-to-platelet count curve and Naranjo's Adverse Drug Reaction Probability Scale score. The platelet count cannot be normalized simply by platelet transfusion alone, and vancomycin discontinuation is essential.
Keywords: Case report; Endocarditis; Literature review; Platelet transfusion; Thrombocytopenia; Vancomycin.
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Figures
Similar articles
-
A rare occurrence of Vancomycin-induced gastrointestinal hemorrhage without thrombocytopenia: a case report and literature review.BMC Infect Dis. 2024 Oct 4;24(1):1105. doi: 10.1186/s12879-024-09949-y. BMC Infect Dis. 2024. PMID: 39367298 Free PMC article. Review.
-
Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody.Pharmacotherapy. 2012 Nov;32(11):e321-5. doi: 10.1002/phar.1132. Epub 2012 Oct 12. Pharmacotherapy. 2012. PMID: 23065779
-
Vancomycin-induced thrombocytopenia: a case proven with rechallenge.Pharmacotherapy. 2003 Sep;23(9):1195-8. doi: 10.1592/phco.23.10.1195.32765. Pharmacotherapy. 2003. PMID: 14524652
-
Rapid onset vancomycin-induced thrombocytopenia confirmed by vancomycin antibody test.BMJ Case Rep. 2021 Jul 26;14(7):e243027. doi: 10.1136/bcr-2021-243027. BMJ Case Rep. 2021. PMID: 34312134 Free PMC article.
-
Vancomycin-Induced Thrombocytopenia: A Narrative Review.Drug Saf. 2017 Jan;40(1):49-59. doi: 10.1007/s40264-016-0469-y. Drug Saf. 2017. PMID: 27848200 Review.
Cited by
-
Severe vancomycin-induced thrombocytopenia in a patient with meningitis.BMJ Case Rep. 2021 Aug 13;14(8):e244209. doi: 10.1136/bcr-2021-244209. BMJ Case Rep. 2021. PMID: 34389597 Free PMC article.
-
Drug-Induced Thrombocytopenia: A Case Involving Vancomycin.Cureus. 2023 Jul 14;15(7):e41874. doi: 10.7759/cureus.41874. eCollection 2023 Jul. Cureus. 2023. PMID: 37581131 Free PMC article.
-
Vancomycin-Induced Thrombocytopenia in a 35-Year-Old Female With Pneumonia: A Case Report.Cureus. 2023 Sep 25;15(9):e45945. doi: 10.7759/cureus.45945. eCollection 2023 Sep. Cureus. 2023. PMID: 37753064 Free PMC article.
-
Incidence and risk factors of Vancomycin-induced thrombocytopenia: a six-year real-world study.BMC Infect Dis. 2025 Jan 2;25(1):7. doi: 10.1186/s12879-024-10393-1. BMC Infect Dis. 2025. PMID: 39748286 Free PMC article.
-
Re-exposure causing rapid onset of vancomycin induced thrombocytopenia.IDCases. 2022 Jan 11;27:e01398. doi: 10.1016/j.idcr.2022.e01398. eCollection 2022. IDCases. 2022. PMID: 35079574 Free PMC article.
References
-
- Patel N, VanDeWall H, Tristani L, Rivera A, Woo B, Dihmess A, Li HK, Smith R, Lodise TP. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin. J Antimicrob Chemother. 2012;67:727–735. - PubMed
-
- Rao N, Ziran BH, Wagener MM, Santa ER, Yu VL. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections. Clin Infect Dis. 2004;38:1058–1064. - PubMed
-
- van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf. 2004;27:1243–1252. - PubMed
-
- Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580–587. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources